H.C. Wainwright Downgrades Sarepta Therapeutics (SRPT) to Sell
Tweet Send to a Friend
(Updated - June 16, 2025 6:35 AM EDT)
H.C. Wainwright analyst Mitchell S. Kapoor downgraded Sarepta Therapeutics (NASDAQ: SRPT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Mitchell S. Kapoor downgraded Sarepta Therapeutics (NASDAQ: SRPT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
